Redilev vs. Keppra – what’s the difference?
| Feature | Redilev | Keppra (levetiracetam) |
|---------|---------|------------------------|
| What it is | In most references, Redilev is a brand‑name formulation of levetiracetam (the same active ingredient as Keppra). It is sold in a few countries (e.g., India, some Asian markets). | Brand name for levetiracetam, a well‑established antiepileptic medication available worldwide. |
| Active ingredient | Levetiracetam | Levetiracetam |
| Mechanism of action | Binds to synaptic vesicle protein 2A (SV2A), modulating neurotransmitter release and dampening neuronal hyperexcitability. | Same mechanism: SV2A binding; no significant metabolism by liver enzymes (so minimal drug–drug interactions). |
| Indications | • Partial (focal) seizures (with or without secondary generalization) in adults and children.
• Myoclonic seizures (often in juvenile myoclonic epilepsy).
• Adjunctive therapy for complex partial seizures in children ≥1 yr. | • Partial (focal) seizures (with or without secondary generalization).
• Myoclonic seizures.
• Adjunctive therapy for complex partial seizures in children ≥1 yr.
• Status epilepticus (IV formulation). |
| Formulations | Oral tablets, oral solution, IV (in countries where the IV brand is available). | Oral tablets, oral solution, IV (in the U.S. and many other countries). |
| Typical dosing (oral) | • Adults: 500 mg BID → 1500–3000 mg/day (titrated).
• Children: 10 mg/kg/day → 20 mg/kg/day (max 3000 mg/day). | • Adults: 500 mg BID → 1500–3000 mg/day (titrated).
• Children: 10 mg/kg/day → 20 mg/kg/day (max 3000 mg/day).
• Pediatric IV: 2 mg/kg → 4 mg/kg IV over 15–30 min. |
| Pharmacokinetics | Rapid absorption; peak plasma ~1 h. ~70 % renal clearance; half‑life 7 h. | Same as above. No hepatic metabolism. |
| Common side effects | Dizziness, fatigue, headache, irritability, nausea. Rare: allergic rash, suicidal thoughts. | Same spectrum. Also “irritability” and “suicidal ideation” are listed in the FDA black box. |
| Drug interactions | Minimal. It does not inhibit or induce CYP450 enzymes, so it rarely alters the levels of other drugs. | Same. Can be co‑administered with valproate, carbamazepine, etc., with no major interaction. |
| Contraindications | Hypersensitivity to levetiracetam. | Same. |
| Warnings | • Use with caution in patients with impaired renal function.
• Monitor mood and behavior. | • Same. |
| Cost/Access | In countries where it’s sold, it may be cheaper than the brand name Keppra, but price varies. | In the U.S., Keppra is brand‑name; generics (e.g., “Levetiracetam” generic) are available and cheaper. |
| Availability | Mostly in specific markets (e.g., India, some Asian countries). | Widely available globally. |
Bottom line
- Redilev is not a separate drug—it is essentially levetiracetam under a different brand name.
- The efficacy, dosing, side‑effect profile, and interactions are virtually identical to Keppra.
- The choice between them is usually a matter of availability and cost rather than clinical difference.
If you’re unsure about a prescription labeled “Redilev”
1. Confirm the active ingredient with your pharmacist or prescriber.
2. Check the packaging: the name of the active drug should appear on the label (e.g., “LEVETIRACETAM 500 mg”).
3. Ask your provider if they specifically recommended Redilev and why, especially if it’s a brand not common in your country.
---
Quick FAQ
| Question | Answer |
|----------|--------|
| Is Redilev less safe than Keppra? | No – the active ingredient is the same, so safety and efficacy are comparable. |
| Will switching from Keppra to Redilev affect my seizure control? | Not if the same dose is used. The pharmacology is identical. |
| Can I take Redilev and Keppra at the same time? | No need; it would double the levetiracetam dose. |
| What if my kidneys don’t work well? | Both drugs are renally cleared. Dose adjustments are required. |
If you have any more specific questions—such as dosing for a particular age group, how to handle missed doses, or concerns about mood changes—feel free to let me know!